Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

AMBS MC = $1.47-Mil. as of 05/10 COB



Assets worth $500-Mil....? Oh really now? Then why are you trying to lure in the unsuspecting and novice investor into giving YOU their hrad earned honest money?

And surprise suprise - if no one noticed the endothelial cell COVID-19 application for MANF in the PR, its because no one wants to be burned again by this atrocious security that was run head-first into the proverbial ground at super-sonic speed no less, all with the likes of serial toxic death spiral financing that YOU signed repeatedly - the last of which was floorless with a notorious offshore hedgie. Don't believe me, read all about all the inuendos, pie-in-the-sky deliverables, half truths, inconsistent managerial execution, continuous broken commitments, and failed "financial engineering" here - if you can actually stomach your own words:



Build shareholder value my arse! And back at it - almost 11 years later - and you think you have ANY credibility left whatsoever...???

https://www.businesswire.com/news/home/20111028005293/en/Amarantus-BioSciences-Appoints-Gerald-Commissiong-President-CEO

October 28, 2011: In commenting on the appointment, Chairman Cleary said, “I congratulate Gerald and wish him the very best in this important assignment. Together, we succeeded in making Amarantus a public entity in a very difficult financial market and now it’s time to build shareholder value by advancing the development of the company’s lead product development program and corporate strategies. Gerald is ideally suited to direct this effort.” In commenting on the appointment, Chairman Cleary said, “I congratulate Gerald and wish him the very best in this important assignment. Together, we succeeded in making Amarantus a public entity in a very difficult financial market and now it’s time to build shareholder value by advancing the development of the company’s lead product development program and corporate strategies. Gerald is ideally suited to direct this effort.”

"I am excited about the opportunity to lead Amarantus at this critical juncture in its development, and would like to thank Marty for his incredible contributions to Amarantus over the last two years,” said Mr. Commissiong. “I intend to establish a focused corporate structure centered on our core competencies in the areas of Parkinson’s disease and Neuroscience.”

All Just My Humble Opinion